Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Additional NICE recommendation for Novartis’ Lucentis

Additional NICE recommendation for Novartis’ Lucentis Novartis has received an additional draft recommendation in macular oedema from the UK's National Institute for Health and Care Excellence (NICE) for Lucentis. ... NICE's final decision on the use of Lucentis visual impairment due to macular oedema

Bayer's Eylea data not suitable, says IQWiG

Bayer's Eylea data not suitable, says IQWiG German HTA body unhappy with Lucentis comparison data and turns down Bayer-Regeneron wet AMD drug. ... drug was superior to Novartis' Lucentis (ranibizumab) in the treatment of wet age-related macular degeneration (AMD).

Novartis, Roche under scrutiny in Italy on Avastin/Lucentis collusion claims

Novartis, Roche under scrutiny in Italy on Avastin/Lucentis collusion claims The active ingredients in both medicines were developed by Roche subsidiary Genentech, with Novartis marketing Lucentis under license in Europe. ... as the publicly-funded CATT and IVAN trials - which found the drug was as effective as Lucentis.

Novartis’ Jakavi turned down by NICE for blood cancer

Novartis’ Jakavi turned down by NICE for blood cancer UK cost-effectiveness watchdog concerned about 'uncertainties' in data in draft guidance

Novartis expects tough 2013 before a return to growth

Novartis expects tough 2013 before a return to growth However, Novartis expects growth in its portfolio of new treatments, including Lucentis, Gilenya, Afinitor and Tasigna, to allow it to report sales growth of at least mid-single digits in 2014

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics